Providencia spp. as emerging clinical pathogens in the era of antimicrobial resistance: From opportunism to global threat: A review
Acta Microbiologica et Immunologica Hungarica · 18.11.2026
DOI: 10.1556/030.2026.03141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, erschienen am 18.11.2026. Verfasst von Turki Asiri. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Providencia species are increasingly recognized as clinically important opportunistic pathogens, particularly in healthcare settings where the presence of vulnerable patients, prolonged hospital stays, invasive devices, and exposure to antibiotics contribute to their persistence and spread. Although Providencia spp. are historically viewed as relatively rare causes of human infection, some species such as Providencia stuartii and Providencia rettgeri have emerged as significant pathogens of urinary tract, bloodstream, respiratory, and other healthcare-associated infections. Recent studies have greatly expanded our understanding of this genus, revealing previously unknown species diversity, improved taxonomy, and identified the emergence of internationally disseminated high-risk lineages. Of particular concern is the growing burden of antimicrobial resistance. Providencia combines an intrinsically limited susceptibility profile with an increasing ability to acquire extended-spectrum β -lactamases, carbapenemases, aminoglycoside resistance determinants, quinolone resistance mechanisms, and other resistance genes. Carbapenem resistance, particularly that mediated by NDM-type metallo-β-lactamases (MBLs), has become a major clinical threat. Of great concern, the emergence of multidrug-resistant and extensively drug-resistant strains was reported in Providencia and it is increasingly limiting treatment options. This review summarizes the latest developments in taxonomy, epidemiology, healthcare-associated transmission, mobile genetic elements, antimicrobial resistance, and therapeutic challenges for Providencia species, with emphasis on necessity of future research to strengthen genomic surveillance and antimicrobial resistance monitoring, promote the prudent use of antimicrobials, implement infection prevention measures, and conduct future therapeutic studies to limit further spread and improve the management of these emerging pathogens.
Zitieren
APA
Asiri, T. (2026). Providencia spp. as emerging clinical pathogens in the era of antimicrobial resistance: From opportunism to global threat: A review. Acta Microbiologica et Immunologica Hungarica. https://doi.org/10.1556/030.2026.03141
Vancouver
Asiri T. Providencia spp. as emerging clinical pathogens in the era of antimicrobial resistance: From opportunism to global threat: A review. Acta Microbiologica et Immunologica Hungarica. 2026. doi:10.1556/030.2026.03141
BibTeX
@article{Asiri2026,
author = {Asiri, Turki},
title = {Providencia spp. as emerging clinical pathogens in the era of antimicrobial resistance: From opportunism to global threat: A review},
journal = {Acta Microbiologica et Immunologica Hungarica},
year = {2026},
doi = {10.1556/030.2026.03141}
}
EUVIMED